[ad_1]

3D Techniques has introduced the acquisitions of polymer extrusion 3D printing corporations Titan Additive and Kumovis to develop its play within the industrial and medical markets.
With each offers anticipated to shut in April 2022, 3D Techniques believes the pellet-based know-how of Titan will permit it to handle new purposes within the foundries, transportation, aerospace and normal manufacturing sectors, whereas Kumovis’ providing will strengthen its addressable marketplace for personalised healthcare purposes. It follows 3D Techniques’ acquisitions of Allevi and Additive Works in Could 2021 and its $180m purchase out of Oqton final autumn.
Titan Robotics presents hybrid instrument head configurations (pellet extrusion, filament extrusion and a spindle instrument head for precision ending) which are designed to present prospects elevated flexibility when selecting one of the best mixed format to go well with their utility wants. Combining this functionality with construct chambers measuring 30 x 30 x 45 inches and 50 x 50 x 72 inches, and print speeds as much as 30,000mm per minute, Titan is ready to facilitate the manufacture of ‘massive, industrial components.’ Lately, Titan has continued to construct out its {hardware} portfolio, asserting a brand new system ultimately yr’s AMUG, whereas additionally aligning with Jabil – additionally a 3D Techniques associate – for the provide of pellet extrusion supplies.
By buying Titan, 3D Techniques is assured it now has a bigger play in sand casting, tooling, jigs and fixtures, and end-use components purposes like air ducts, brackets and structural elements.
“With the addition of Titan Robotics’ distinctive extrusion know-how, we will handle our prospects’ wants for big construct volumes, superior efficiency and improved productiveness at a considerably decrease value,” commented 3D Techniques President and CEO Dr Jeffrey Graves. “By the modern modular strategy of their printers, and the power to make use of each pellet and filament product kinds in an open structure with broadly obtainable manufacturing polymer programs, we imagine the adoption price of commercial 3D printing will proceed to speed up. By combining the engineering and purposes experience of Titan Robotics with the worldwide attain of 3D Techniques’ gross sales, service and utility groups, we’re well-positioned to assist our prospects throughout the total vary of our markets.”
“The crew at Titan Robotics is thrilled to grow to be a part of the world-class organisation at 3D Techniques, as Titan’s management crew of Clay Guillory, Invoice Macy, Maddie Guillory and I are dedicated to persevering with Titan’s mission of fixing the standard manufacturing panorama with manufacturing additive manufacturing options,” added Titan Additive CEO Rahul Kasat. “We’re excited by the synergies this acquisition will allow to develop the adoption of commercial 3D printing throughout all kinds of producing industries, as pellet-based extrusion and hybrid manufacturing programs grow to be the brand new requirements for manufacturing purposes.”
Kumovis, in the meantime, presents extrusion know-how particularly developed for the precision printing of medical-grade and high-performance polymers like PEEK. Supplies like PEEK are sometimes deployed for human implants and surgical instrumentation purposes, with Kumovis’ know-how promising medical components which are delivered quicker and obtain higher affected person outcomes. Kumovis’ know-how was made obtainable in August 2019 and since then the corporate has gone on to associate with Hyperganic, increase €3.6m in a Collection A spherical and appoint medtech chief Vincent Gardès as its chairman.
By integrating Kumovis into 3D Techniques’ already wholesome medical actions in Colorado and Leuven, 3D Techniques expects to develop its providing to incorporate PEEK implant manufacturing and bone plates for trauma procedures, whereas constructing on its capability to provide spinal cages.
“As a pioneer in personalised healthcare options, 3D Techniques is constantly looking for alternatives to develop our utility choices that may advance healthcare supply,” supplied Dr Graves. “The addition of the Kumovis crew – their experience and know-how – shall be extremely synergistic to our medical enterprise mannequin. Our confirmed potential to ship regulatory-approved, implantable 3D printed medical units, personalised to enhance affected person outcomes, to surgeons around the globe by our distinctive channel companions, will assist be sure that the Kumovis PEEK-based choices may be delivered to market rapidly and successfully. Furthermore, 3D Techniques’ increasing level of care initiatives shall be significantly enhanced by the inclusion of Kumovis’ distinctive ‘built-in clear room’ printing know-how, permitting hospitals and different end-users to tailor merchandise on-demand, to satisfy particular affected person necessities within the quickest and most resource-efficient method.”
Kumovis co-founder and co-CEO Stefan Leonhardt added: “As well as, by becoming a member of forces with 3D Techniques, we will mix their excellent options with our distinctive PEEK printing know-how to supply environment friendly, validated end-to-end workflows to provide personalised implants and enhance affected person outcomes. We sit up for growing the concentrate on our core competencies to assist speed up the event of the following era of implants and remodel medical system manufacturing.”
Wish to focus on? Be part of the dialog on the Additive Manufacturing International Group Discord.
Get your FREE print subscription to TCT Journal.
[ad_2]
